107 related articles for article (PubMed ID: 32473241)
1. Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.
Kiyasu Y; Kawada K; Hirai H; Ogawa R; Hanada K; Masui H; Nishikawa G; Yamamoto T; Mizuno R; Itatani Y; Kai M; Taketo MM; Sakai Y
Cancer Lett; 2020 Sep; 487():53-62. PubMed ID: 32473241
[TBL] [Abstract][Full Text] [Related]
2. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
3. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.
Hirai H; Fujishita T; Kurimoto K; Miyachi H; Kitano S; Inamoto S; Itatani Y; Saitou M; Maekawa T; Taketo MM
Clin Exp Metastasis; 2014 Dec; 31(8):977-89. PubMed ID: 25326065
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment.
Masui H; Kawada K; Itatani Y; Hirai H; Nakanishi Y; Kiyasu Y; Hanada K; Okamoto M; Hirata W; Nishikawa Y; Sugimoto N; Tamura T; Sakai Y; Obama K
Br J Cancer; 2024 May; ():. PubMed ID: 38750114
[TBL] [Abstract][Full Text] [Related]
5. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice.
Rodero MP; Auvynet C; Poupel L; Combadière B; Combadière C
Neoplasia; 2013 Jun; 15(6):641-8. PubMed ID: 23730212
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.
Kitamura T; Fujishita T; Loetscher P; Revesz L; Hashida H; Kizaka-Kondoh S; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13063-8. PubMed ID: 20616008
[TBL] [Abstract][Full Text] [Related]
8. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
[TBL] [Abstract][Full Text] [Related]
9. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.
Kitamura T; Kometani K; Hashida H; Matsunaga A; Miyoshi H; Hosogi H; Aoki M; Oshima M; Hattori M; Takabayashi A; Minato N; Taketo MM
Nat Genet; 2007 Apr; 39(4):467-75. PubMed ID: 17369830
[TBL] [Abstract][Full Text] [Related]
10. The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis.
Akram IG; Georges R; Hielscher T; Adwan H; Berger MR
Tumour Biol; 2016 Feb; 37(2):2461-71. PubMed ID: 26383527
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.
Zhao L; Lim SY; Gordon-Weeks AN; Tapmeier TT; Im JH; Cao Y; Beech J; Allen D; Smart S; Muschel RJ
Hepatology; 2013 Feb; 57(2):829-39. PubMed ID: 23081697
[TBL] [Abstract][Full Text] [Related]
12. Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment.
Gorden DL; Fingleton B; Crawford HC; Jansen DE; Lepage M; Matrisian LM
Int J Cancer; 2007 Aug; 121(3):495-500. PubMed ID: 17417772
[TBL] [Abstract][Full Text] [Related]
13. Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft.
Yin JH; Zhu XY; Shi WD; Liu LM
BMC Complement Altern Med; 2014 Dec; 14():483. PubMed ID: 25496480
[TBL] [Abstract][Full Text] [Related]
14. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
15. Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.
Lim SY; Gordon-Weeks A; Allen D; Kersemans V; Beech J; Smart S; Muschel RJ
Hepatology; 2015 Aug; 62(2):521-33. PubMed ID: 25854806
[TBL] [Abstract][Full Text] [Related]
16. The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment.
Ciszewski WM; Sobierajska K; Wawro ME; Klopocka W; Chefczyńska N; Muzyczuk A; Siekacz K; Wujkowska A; Niewiarowska J
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2283-2296. PubMed ID: 28893556
[TBL] [Abstract][Full Text] [Related]
17. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.
Rahbari NN; Kedrin D; Incio J; Liu H; Ho WW; Nia HT; Edrich CM; Jung K; Daubriac J; Chen I; Heishi T; Martin JD; Huang Y; Maimon N; Reissfelder C; Weitz J; Boucher Y; Clark JW; Grodzinsky AJ; Duda DG; Jain RK; Fukumura D
Sci Transl Med; 2016 Oct; 8(360):360ra135. PubMed ID: 27733559
[TBL] [Abstract][Full Text] [Related]
19. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
Kim BR; Kang MH; Kim JL; Na YJ; Park SH; Lee SI; Kang S; Joung SY; Lee SY; Lee DH; Min BW; Oh SC
Oncol Rep; 2016 Nov; 36(5):2601-2608. PubMed ID: 27633042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
